$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Discussion on the possibility of treatment of stage IVA nasopharyngeal carcinoma
2026-02-01 22:25:32
Check Details
The best treatment options for nasopharyngeal cancer
2026-02-01 22:25:32
Check Details
What are the main symptoms of advanced nasopharyngeal cancer?
2026-02-01 22:25:32
Check Details
Will patients with advanced nasopharyngeal cancer experience dizziness?
2026-02-01 22:25:32
Check Details
Early screening methods for nasopharyngeal cancer
2026-02-01 22:25:32
Check Details
Will the nose become bigger due to nasopharyngeal cancer?
2026-02-01 22:25:32
Check Details
Is alternating nasal obstruction associated with nasopharyngeal cancer?
2026-02-01 22:25:32
Check Details
Can nasopharyngeal cancer tumors be seen in the nose?
2026-02-01 22:25:32
Check Details
Which groups are more likely to have nasopharyngeal cancer recurrence?
2026-02-01 22:25:32
Check Details
Will nasopharyngeal cancer cause nausea and vomiting symptoms?
2026-02-01 22:25:32
Check Details
Can Vigabatrin cause blindness?
2026-02-01 22:25:32
Check Details
A complete analysis of the side effects of Vigabatrin anti-epileptic drugs
2026-02-01 22:25:32
Check Details
1
2
...
1186
1187
1188
1189
1190
1191
1192
...
10224
10225
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
2
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor
3
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
4
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
5
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
6
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
7
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
8
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
9
Ponatinib: A Third-Generation TKI Targeting BCR::ABL1 to Overcome Leukemia Drug Resistance
10
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
11
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
12
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview